SCHEMBL3045237

SCHEMBL3045237

Cn1c(=O)oc2cc(N)ccc21

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
PKM P14618 7/20 0.50
TSHR P16473 2/20 0.50
POLB P06746 2/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 2/20 0.48
BRPF1 P55201 2/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GFER P55789 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29878389 1.00 ALDH1A1 (0.53) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL30022934 0.85 DDB1 (0.46) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL399737 0.85 DDB1 (0.46) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL1025445 0.79 PKM (0.58) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL16846965 0.79 NPC1 (0.41) ALDH1A1HPGDKDM4EBRPF1MEN1
SCHEMBL9437718 0.78 ALDH1A1 (0.50) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL6348798 0.78 ALDH1A1 (0.53) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL2308656 0.78 PKM (0.59) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL5536572 0.78 PKM (0.59) ALDH1A1HPGDPKMTSHRPOLB
SCHEMBL5539787 0.78 MEN1 (0.59) ALDH1A1HPGDPKMTSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113087922-A Clover-shaped metal organic supermolecule and preparation method and application thereof 广州大学 2021-07-09 CN claimed
US-12590066-B2 Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2026-03-31 US disclosed
WO-2025245484-A1 FOXN1 ACTIVATORS THYMOFOX INC. (US) 2025-11-27 WO disclosed
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 US disclosed
CN-114671878-B Substituted nitrogen-containing bicyclic compounds and uses thereof 广东东阳光药业有限公司 2023-08-04 CN disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 EP disclosed
CN-115867277-A Novel fused heterocyclyl-carbohydrazone acyldinitrile compounds and use thereof 韩国科学技术研究院 2023-03-28 CN disclosed
US-20220396553-A1 NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-12-15 US disclosed
US-20020016492-A1 Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones MERCK SHARP & DOHME CORP. 2002-02-07 US disclosed
EP-0775107-B1 PREPARATION OF O-(2-HYDROXYALKYL) OXIMES BASF AG (DE) 1999-10-13 EP disclosed
US-5618964-A Prodrug esters of phosphonosulfonate squalene synthetase inhibitors and method BRISTOL-MYERS SQUIBB COMPANY (US) 1997-04-08 US disclosed
CN-1015334-B PREPARATION METHOD FOR DERIVERTIVES PFIZER (PA) 1992-01-29 CN disclosed
US-5036088-A Enzyme inhibitors; cyclooxygenase, lipoxygenase PFIZER INC. (US) 1991-07-30 US disclosed
US-5006541-A Antiallergy and antiinflammatory agents PFIZER INC. (US) 1991-04-09 US disclosed
US-4904685-A Antiallergy and antiinflammatory agents PFIZER INC. (US) 1990-02-27 US disclosed
US-4835166-A LIPOXYGENASE, CYCLOOXYGENASE INHIBITORS PFIZER INC. (US) 1989-05-30 US disclosed
CN-87104099-A Anti-allergic and antiphlogistic medicament 1988-02-10 CN disclosed
EP-0249407-A2 Antiallergy and antiinflammatory agents Pfizer Corporation (PA) 1987-12-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 ALDH1A1 1306/4885HPGD 207/4885PKM 327/4885
US-20020016492-A1 Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones CCR1, CCR5, CCR6 ALDH1A1 2952/4885HPGD 392/4885PKM 3418/4885
US-12590066-B2 Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CLIC1 ALDH1A1 592/4885HPGD 2277/4885PKM 3992/4885
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT ALDH1A1 1343/4885HPGD 938/4885PKM 3008/4885
US-20220396553-A1 NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF AANAT, NAT1, HNMT ALDH1A1 402/4885HPGD 544/4885PKM 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.